O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. 2006

Karl-Josef Langen, and Kurt Hamacher, and Matthias Weckesser, and Frank Floeth, and Gabriele Stoffels, and Dagmar Bauer, and Heinz H Coenen, and Dirk Pauleit
Institute of Medicine, Research Center Jülich, D-52425 Jülich, Germany. k.j.langen@fz-juelich.de

O-(2-[18F]fluoroethyl)-L-tyrosine (FET) is a promising tracer for PET that has demonstrated convincing results especially in the diagnostics of brain tumors. In contrast to other radiolabeled amino acids, it can be produced with high efficiency and distributed in a satellite concept like the widely used 2-[18F]fluoro-2-deoxy-D-glucose. Although FET is not incorporated into proteins, it shows high uptake in cerebral gliomas and in extracranial squamous cell carcinomas owing to increased transport. The tracer exhibits high in vivo stability, low uptake in inflammatory tissue and suitable uptake kinetics for clinical imaging, which indicates that it may become a new standard tracer for PET. In this article, the present knowledge on the uptake mechanisms and the clinical applications of FET are reviewed and the clinical perspectives are discussed.

UI MeSH Term Description Entries
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D005462 Fluorine Radioisotopes Unstable isotopes of fluorine that decay or disintegrate emitting radiation. F atoms with atomic weights 17, 18, and 20-22 are radioactive fluorine isotopes. Radioisotopes, Fluorine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D014443 Tyrosine A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin. L-Tyrosine,Tyrosine, L-isomer,para-Tyrosine,L Tyrosine,Tyrosine, L isomer,para Tyrosine
D049268 Positron-Emission Tomography An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower. PET Imaging,PET Scan,Positron-Emission Tomography Imaging,Tomography, Positron-Emission,Imaging, PET,Imaging, Positron-Emission Tomography,PET Imagings,PET Scans,Positron Emission Tomography,Positron Emission Tomography Imaging,Positron-Emission Tomography Imagings,Scan, PET,Tomography Imaging, Positron-Emission,Tomography, Positron Emission

Related Publications

Karl-Josef Langen, and Kurt Hamacher, and Matthias Weckesser, and Frank Floeth, and Gabriele Stoffels, and Dagmar Bauer, and Heinz H Coenen, and Dirk Pauleit
October 2020, Molecular imaging and biology,
Karl-Josef Langen, and Kurt Hamacher, and Matthias Weckesser, and Frank Floeth, and Gabriele Stoffels, and Dagmar Bauer, and Heinz H Coenen, and Dirk Pauleit
November 2016, European journal of nuclear medicine and molecular imaging,
Karl-Josef Langen, and Kurt Hamacher, and Matthias Weckesser, and Frank Floeth, and Gabriele Stoffels, and Dagmar Bauer, and Heinz H Coenen, and Dirk Pauleit
September 2014, Journal of nuclear medicine technology,
Karl-Josef Langen, and Kurt Hamacher, and Matthias Weckesser, and Frank Floeth, and Gabriele Stoffels, and Dagmar Bauer, and Heinz H Coenen, and Dirk Pauleit
July 2018, EJNMMI research,
Karl-Josef Langen, and Kurt Hamacher, and Matthias Weckesser, and Frank Floeth, and Gabriele Stoffels, and Dagmar Bauer, and Heinz H Coenen, and Dirk Pauleit
January 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Karl-Josef Langen, and Kurt Hamacher, and Matthias Weckesser, and Frank Floeth, and Gabriele Stoffels, and Dagmar Bauer, and Heinz H Coenen, and Dirk Pauleit
October 2019, Neuro-oncology,
Karl-Josef Langen, and Kurt Hamacher, and Matthias Weckesser, and Frank Floeth, and Gabriele Stoffels, and Dagmar Bauer, and Heinz H Coenen, and Dirk Pauleit
August 2013, Nuclear medicine and biology,
Karl-Josef Langen, and Kurt Hamacher, and Matthias Weckesser, and Frank Floeth, and Gabriele Stoffels, and Dagmar Bauer, and Heinz H Coenen, and Dirk Pauleit
March 2017, European journal of nuclear medicine and molecular imaging,
Karl-Josef Langen, and Kurt Hamacher, and Matthias Weckesser, and Frank Floeth, and Gabriele Stoffels, and Dagmar Bauer, and Heinz H Coenen, and Dirk Pauleit
February 2019, Molecular imaging and biology,
Karl-Josef Langen, and Kurt Hamacher, and Matthias Weckesser, and Frank Floeth, and Gabriele Stoffels, and Dagmar Bauer, and Heinz H Coenen, and Dirk Pauleit
December 2002, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine,
Copied contents to your clipboard!